Stella Pharma (TSE:4888) Net Margin %: -383.94% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4888 Stella Pharma Corp TSE:4888
74 GF Score
Price 円325.00
GF Value 円337.87
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stella Pharma Net Margin %?

Stella Pharma TSE:4888 -0.31% 74 Net Margin % is -383.94% as of Mar. 2026. GuruFocus rates TSE:4888 with a GF Score™ of 74/100 and a GF Value™ of 円337.87 (Fairly Valued). The stock has 4 warning signs investors should review. Among 941 Biotechnology companies, Stella Pharma ranks worse than 62.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Stella Pharma's Net Income for the six months ended in Mar. 2026 was 円-473.0 Mil. Stella Pharma's Revenue for the six months ended in Mar. 2026 was 円123.2 Mil. Therefore, Stella Pharma's net margin for the quarter that ended in Mar. 2026 was -383.94%.

The historical rank and industry rank for Stella Pharma's Net Margin % or its related term are showing as below:

TSE:4888' s Net Margin % Range Over the Past 10 Years
Min: -766.98   Med: -301.74   Max: -14.65
Current: -241.48

TSE:4888's Net Margin % is ranked worse than
62.7% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs TSE:4888: -241.48

Stella Pharma  (TSE:4888) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Stella Pharma Net Margin % Related Terms

Stella Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Stella Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stella Pharma Net Margin % Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial -766.98 -340.00 -283.40 -14.65 -241.48

Stella Pharma Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -396.46 -158.64 16.16 -153.81 -383.94

TSE:4888 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Stella Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Stella Pharma's Net Margin % falls into.


TSE:4888
74GF Score
Stella Pharma Corp TSE:4888
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stella Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Stella Pharma's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-780.917/323.389
=-241.48 %

Stella Pharma's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-473.002/123.196
=-383.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -383.94% mean?
Stella Pharma (TSE:4888) has a Net Margin % of -383.94% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Stella Pharma and its competitors. According to the industry distribution chart, Stella Pharma ranks #590 out of 941 companies in the Biotechnology industry, placing it in the top 62.7%.
Is Stella Pharma's Net Margin % too high?
Stella Pharma's current Net Margin % is -383.94%. Based on the distribution chart, Stella Pharma ranks #590 out of 941 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Stella Pharma has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stella Pharma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Stella Pharma ranks #590 out of 941 companies for Net Margin %. This places Stella Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Stella Pharma and its competitors. Stella Pharma's current Net Margin % is -383.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Pharma stock overvalued right now?
Based on GuruFocus' analysis, Stella Pharma (TSE:4888) is currently considered Fairly Valued. The stock's GF Value™ is 円337.87, compared to a current price of 円325.00 — trading 3.8% below its estimated fair value. The current Net Margin % is -383.94%. Stella Pharma's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Stella Pharma (TSE:4888), the current Net Margin % is -383.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stella Pharma (TSE:4888) Overvalued in 2026?

Based on GuruFocus' analysis, Stella Pharma stock appears to be undervalued. The current stock price of 円325.00 is trading 3.8% below its estimated GF Value™ of 円337.87. GuruFocus considers Stella Pharma to be Fairly Valued.

Key valuation signals for TSE:4888:

  • Net Margin %: -383.94%
  • GF Value™: 円337.87 vs. price of 円325.00 (3.8% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the TSE:4888 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stella Pharma Business Description

Address 3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
74GF Score

Get the complete analysis for TSE:4888

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円325.00
Price
円337.87
GF Value